Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1596291rdf:typepubmed:Citationlld:pubmed
pubmed-article:1596291lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C0000854lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C0205169lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C0178666lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C2699518lld:lifeskim
pubmed-article:1596291lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:1596291pubmed:issue9lld:pubmed
pubmed-article:1596291pubmed:dateCreated1992-6-26lld:pubmed
pubmed-article:1596291pubmed:abstractTextThe intestinal absorption of glucose- and galactose-conjugated compounds was studied in the everted sac of the rat small intestine. The absorption clearance of p-nitrophenyl beta-D-glucopyranoside (p-NPglc) at 250 microM in the mucosal side (4.45 +/- 0.34 microL/min/cm, mean +/- SE, N = 4), calculated by dividing the absorption rate by the drug concentration, was significantly decreased (0.476 +/- 0.036 microL/min/cm) in the presence of 1 mM phloridzin, an inhibitor of glucose transport, and in the absence of Na+, a cosubstrate of the glucose transport carrier (0.424 +/- 0.018 microL/min/cm). The absorption clearance of p-NPglc was decreased as its concentration increased. In the same experiment, the absorption clearance of p-nitrophenyl beta-D-galactopyranoside (1.99 +/- 0.23 microL/min/cm) was also significantly decreased in the presence of phloridzin and in the absence of Na+. However, the absorption clearance of p-nitrophenyl beta-D-mannopyranoside (0.811 +/- 0.013 microL/min/cm) was low and not significantly decreased in the presence of phloridzin (P greater than 0.1). Furthermore, the absorption clearance of beta-naphthyl beta-D-glucopyranoside and beta-naphthyl beta-D-galactopyranoside was also significantly decreased in the presence of phloridzin (P less than 0.001). These results indicated that the glucose and galactose moieties provided these compounds with a new route by way of the glucose transport carrier for intestinal absorption.lld:pubmed
pubmed-article:1596291pubmed:languageenglld:pubmed
pubmed-article:1596291pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:citationSubsetIMlld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1596291pubmed:statusMEDLINElld:pubmed
pubmed-article:1596291pubmed:monthMaylld:pubmed
pubmed-article:1596291pubmed:issn0006-2952lld:pubmed
pubmed-article:1596291pubmed:authorpubmed-author:HayashiMMlld:pubmed
pubmed-article:1596291pubmed:authorpubmed-author:OhtaKKlld:pubmed
pubmed-article:1596291pubmed:authorpubmed-author:AwazuSSlld:pubmed
pubmed-article:1596291pubmed:authorpubmed-author:MizumoFFlld:pubmed
pubmed-article:1596291pubmed:issnTypePrintlld:pubmed
pubmed-article:1596291pubmed:day8lld:pubmed
pubmed-article:1596291pubmed:volume43lld:pubmed
pubmed-article:1596291pubmed:ownerNLMlld:pubmed
pubmed-article:1596291pubmed:authorsCompleteYlld:pubmed
pubmed-article:1596291pubmed:pagination2037-9lld:pubmed
pubmed-article:1596291pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:meshHeadingpubmed-meshheading:1596291-...lld:pubmed
pubmed-article:1596291pubmed:year1992lld:pubmed
pubmed-article:1596291pubmed:articleTitleIntestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs.lld:pubmed
pubmed-article:1596291pubmed:affiliationDepartment of Biopharmaceutics, Tokyo College of Pharmacy, Japan.lld:pubmed
pubmed-article:1596291pubmed:publicationTypeJournal Articlelld:pubmed